1	Decreased	decrease	_	_	_	_	_	_	_
2	proteasome-mediated	proteasome-mediated	_	_	_	_	_	_	_
3	degradation	degradation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	elderly	elderly	_	_	_	_	_	_	_
10	:	:	_	_	_	_	_	_	_
11	A	a	_	_	_	_	_	_	_
12	role	role	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	immune	immune	_	_	_	_	_	_	_
15	senescence	senescence	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NFkappaB	NFkappaB	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	highly	highly	_	_	_	_	_	_	_
7	regulated	regulate	_	_	_	_	_	_	_
8	process	process	_	_	_	_	_	_	_
9	requiring	require	_	_	_	_	_	_	_
10	phosphorylation	phosphorylation	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	ubiquitination	ubiquitination	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	proteasome-mediated	proteasome-mediated	_	_	_	_	_	_	_
16	degradation	degradation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	cytosolic	cytosolic	_	_	_	_	_	_	_
20	inhibitor	inhibitor	_	_	_	_	_	_	_
21	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Analyses	analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	regulation	regulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	TNF-alpha-treated	tnf-alpha-treated	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	young	young	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	elderly	elderly	_	_	_	_	_	_	_
15	donors	donor	_	_	_	_	_	_	_
16	revealed	reveal	_	_	_	_	_	_	_
17	severely	severely	_	_	_	_	_	_	_
18	compromised	compromise	_	_	_	_	_	_	_
19	degradation	degradation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	elderly	elderly	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Examination	Examination	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	activation-induced	activation-induced	_	_	_	_	_	_	_
4	phosphorylation	phosphorylation	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	ubiquitination	ubiquitination	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
9	did	do	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	demonstrate	demonstrate	_	_	_	_	_	_	_
12	any	any	_	_	_	_	_	_	_
13	significant	significant	_	_	_	_	_	_	_
14	age-related	age-related	_	_	_	_	_	_	_
15	alterations	alteration	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	examination	examination	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	proteasome	proteasome	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	using	use	_	_	_	_	_	_	_
12	fluorogenic	fluorogenic	_	_	_	_	_	_	_
13	peptide	peptide	_	_	_	_	_	_	_
14	assays	assay	_	_	_	_	_	_	_
15	revealed	reveal	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	significant	significant	_	_	_	_	_	_	_
18	age-related	age-related	_	_	_	_	_	_	_
19	decline	decline	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	chymotryptic	chymotryptic	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	decline	decline	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	proteasome	proteasome	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	results	result	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	failure	failure	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	fully	fully	_	_	_	_	_	_	_
16	degrade	degrade	_	_	_	_	_	_	_
17	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	elderly	elderly	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	failure	failure	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	degrade	degrade	_	_	_	_	_	_	_
5	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	underlie	underlie	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	observed	observe	_	_	_	_	_	_	_
11	decrease	decrease	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	NFkappaB	NFkappaB	_	_	_	_	_	_	_
14	induction	induction	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	IL-2	il-2	_	_	_	_	_	_	_
18	receptor	receptor	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	TNF-treated	tnf-treated	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	during	during	_	_	_	_	_	_	_
25	aging	aging	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	decreased	decrease	_	_	_	_	_	_	_
4	proteasome-mediated	proteasome-mediated	_	_	_	_	_	_	_
5	degradation	degradation	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	central	central	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	immune	immune	_	_	_	_	_	_	_
11	dysfunction	dysfunction	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	accompanies	accompany	_	_	_	_	_	_	_
14	aging	aging	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Copyright	Copyright	_	_	_	_	_	_	_
2	1999	1999	_	_	_	_	_	_	_
3	Academic	Academic	_	_	_	_	_	_	_
4	Press	Press	_	_	_	_	_	_	_
5	.	.	_	_	_	_	_	_	_

